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Optical Coherence Tomography
or Intravascular Ultrasound?*
Ik-Kyung Jang, MD, PHD
Boston, Massachusetts
Intravascular ultrasound (IVUS) has been an important
modality in understanding the in vivo pathophysiology of
coronary artery disease and in predicting outcome of per-
cutaneous coronary intervention (PCI). The IVUS features
associated with acute coronary syndromes include positive
remodeling, large plaque burden, ruptured plaque, and
intracoronary thrombus. Plaque burden, lesion site calcium,
and positive remodeling have been reported to be associated
with no-reflow phenomenon and periprocedural myocardial
necrosis after PCI (1,2).
See page 483
Attempts to characterize coronary plaques using IVUS were
less successful. Although some studies showed that lipid
pool-like hypoechoic plaques on IVUS may be associated
with periprocedural myocardial infarction, conflicting stud-
ies have been reported. It was generally accepted that IVUS
is not an ideal tool to detect lipid-rich plaque. However, recent
studies reported that echo-attenuated plaque on gray scale
IVUS was associated with no-reflow and/or elevated creatine
kinase-myocardial band (CK-MB) after PCI, which indicates
that this type of plaque contains vasoactive substances, throm-
bogenic substrates, or rigid material including cholesterol
crystal that does not go through the capillary system, causing
distal embolization with resultant myocardial necrosis (3,4).
The difference between the previously reported hy-
poechoic plaque and echo-attenuated plaque is that atten-
uated plaque has deep ultrasound attenuation (hypoechoic
area) without calcification or very dense fibrous plaque. An
important methodological difference is that, in the previous
studies, low-resolution IVUS (25 or 30 MHz) probes were
used, whereas only higher-resolution 40-MHz probes were
exclusively used in recent studies. Pathological studies and
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was lipid core, microcalcification, fibrofatty tissue with necrotic
core, thrombus, cholesterol crystal, or hyalinization with scat-
tered, small calcified areas (5,6). An animal experiment showed
hat microcalcification and thrombus with underlying ad-
anced atherosclerosis were responsible for echo attenuation.
In the study by Lee et al. (7) in this issue of JACC:
ardiovascular Interventions, echo-attenuated plaque was
ound in 34.8% of patients and was associated with optical
oherence tomography (OCT)-derived thin capped fibro-
theroma (TCFA) and greater lipid content. Of note, most
atients (107 of 135; 79%) had stable angina. Interestingly,
previous study showed 0% echo-attenuated plaque in
table patients and 25.5% in acute coronary syndrome
atients (4). Although intraobserver and interobserver vari-
bility were excellent in this study (kappa  0.91 and 0.85,
espectively), the discrepancy between the 2 studies indi-
ates the intrinsic problem of subjective interpretation and
he absence of standard definition.
The new information from this study is the OCT
ndings of echo-attenuated plaques. A little more than
ne-half (51.1%) of the echo-attenuated plaques had OCT-
erived TCFA (vs. 21.6% in the nonattenuated group). The
uestion is, “What do the other one-half (48.9%) of the
ttenuated plaques have?” Because the thin fibrous cap is
elow the resolution of IVUS (the difference in fibrous cap
hickness between the groups was only 25 m), echo
attenuation might have been due to lipid core. Indeed,
lipid-rich plaque was found in 89.4% of the attenuated
plaques. However, lipid-rich plaque was also found in
55.7% of the nonattenuated plaques. The incidence of
thrombus between the groups was not different. These data
indicate that structural differences between attenuated
plaques and nonattenuated plaques could not be discerned
by OCT. It is unclear what the real nature of echo
attenuation is. Despite the high prevalence of lipid-rich
plaque, less than one-half of patients with attenuated plaque
had post-PCI CK-MB elevation. Although co-registration
is always an issue when 2 different intravascular imaging
modalities are used to study a plaque, it is unclear whether
the findings in this study can be explained by this technical
registration problem.
Multivariable logistic regression analysis showed 2 pre-
dictors for post-PCI CK-MB elevation: attenuated plaque
by IVUS and ruptured plaque by OCT. A question remains
with regard to whether IVUS or OCT would better predict
the post-procedural CK-MB elevation. The odds ratio was
higher with attenuated plaque than with ruptured plaque.
Neither OCT-derived lipid-rich plaque nor TCFA were
identified as a predictor for post-procedural myocardial
necrosis.
Since most components of a coronary plaque are below
the resolution of noninvasive imaging tests such as mul-
tislice computed tomography or cardiac magnetic resonance,
J A C C : C A R D I O V A S C U L A R I N T E R V E N T I O N S , V O L . 4 , N O . 5 , 2 0 1 1 Jang
MA Y 2 0 1 1 : 4 9 2 – 4 Editorial Comment
493intravascular modalities have been the focus of the investi-
gation to characterize coronary plaques and to detect vul-
nerable plaques (8). Among those, IVUS and OCT have
been the most extensively studied (Table 1). Until the
second- generation frequency domain C7 OCT system was
developed, OCT remained a research tool despite its higher
resolution, mainly due to 2 reasons. First, a blood-free zone
has to be created. Among the different techniques used to
displace red blood cells, proximal occluding balloon with
saline infusion was most widely used. This approach re-
quires multiple wire and catheter exchanges and obstruction
of blood flow during imaging. All these steps required time
and posed potential risk. Second, the image depth was
shallow. It was often difficult to visualize coronary arteries with
a diameter 3 mm. Now, with the introduction of the C7
system these 2 problems have been basically solved. The only
difference in use between OCT and IVUS is that clear solution
(contrast or Dextran [Hospira Inc., Lake Forest, Illinois])
should be injected through the guiding catheter during OCT
imaging. It can be done by a power injector using contrast or
Dextran (14 ml at 4 ml/s) or by hand injection using a 20 ml
syringe. This step (connecting a manifold to an injector and
delivering solution) usually takes less than a few minutes. Since
pullback time is much shorter with OCT (3 to 4 s), the total
time required for imaging is comparable between the 2
techniques. The scan depth has also improved with the new
C7 system. Vessels with a diameter up to 3.5 mm can easily be
visualized. Large vessels such as vein graft or left main, and
ostial lesions remain a challenge for OCT.
The most striking difference between the 2 modalities is
the resolution (12 to 15 m in OCT vs. 150 m in IVUS).
One of the reasons why IVUS has not been widely used in
the United States is that it requires a learning period and
Table 1. Comparison: OCT Versus IVUS
OCT IVUS
Frame rate (s) 100 30
Pullback speed (mm/s) 20 0.5–1.0
Lines per frame 500 256
Axial resolution (m) 12 –15 150
Scan diameter in contrast (mm) 10 15 –20
Tissue penetration (mm) 1.0–2.0 10
Ease of use  /
Need for contrast or Dextran Yes No
Detection of lipid  /
Detection of ﬁbrous cap  
Detection of thrombus  
Detection of calcium  
Dissection  
Malapposition  
Stent strut surface coverage  
OCT  optical coherence tomography; IVUS  intravascular ultrasound;   ok;   good; excellent.some experience to be able to interpret images. Even after
some experience it is not always easy to interpret certain
images such as thrombus and tissue prolapse. On the other
hand, the learning curve of OCT is such that one does not
need much experience to interpret images. A new problem,
however, is that we see so many details that we have never
seen before such as plaque disruption, microdissection,
thrombus, tissue prolapse/protrusion, tissue covering previ-
ous stent strut surface, macrophage, and cholesterol crystals.
Following stent placement malapposition is a frequent
finding on OCT images. Recently, a new analysis system
was developed to objectively analyze the optical property of
tissue, which can be used to study changes in the optical
properties of neointima inside previous stents over time.
Clinical significance of these findings is unknown at pres-
ent. Long-term follow up of a large number of patients
would be required to understand the importance of this
novel information and to know if treatment should be
employed. The main question is which modality we should
choose, if we were to use one. For better understanding of
vascular biology, OCT would be far superior to IVUS. For
the majority of PCI cases, I believe frequency domain OCT
can now replace IVUS. For large vessels (diameter 4.0
mm), ostial lesions, or very tight lesions, IVUS would
provide more information. There is no significant difference
in safety. In our institution we have over 10 years of
experience with OCT, but there have been no OCT-related
complications such as major dissection, ventricular tachyar-
rhythmia, or acute renal failure.
In this study, 4% (6 of 135) of patients had post-
procedural CK-MB elevation more than 3 times the upper
limit and 26% (36 of 135) of patients had CK-MB elevation
between 1 and 3 times the upper limit. The question is
whether we should try to prevent or reduce periprocedural
myocardial necrosis and, if so, when and how. Should we
target 4% or 26% of patients? What should be used:
pharmacological therapy such as vasodilators or more effec-
tive antithrombotic agents or protection devices? Many
studies can be designed to answer these questions. However,
before we try to focus on prevention or treatment, we should
first find better predictors for post-PCI myocardial necrosis.
Reprint requests and correspondence: Dr. Ik-Kyung Jang, Car-
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